| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |